MX2018001296A - Proceso para la sintesis de ravidasvir. - Google Patents

Proceso para la sintesis de ravidasvir.

Info

Publication number
MX2018001296A
MX2018001296A MX2018001296A MX2018001296A MX2018001296A MX 2018001296 A MX2018001296 A MX 2018001296A MX 2018001296 A MX2018001296 A MX 2018001296A MX 2018001296 A MX2018001296 A MX 2018001296A MX 2018001296 A MX2018001296 A MX 2018001296A
Authority
MX
Mexico
Prior art keywords
ravidasvir
synthesis
preparation
disclosed
intermediates useful
Prior art date
Application number
MX2018001296A
Other languages
English (en)
Inventor
Gaboardi Mauro
Castaldi Graziano
Baruto Alessandro
Oldani Erminio
Original Assignee
Hc Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hc Pharma Ag filed Critical Hc Pharma Ag
Publication of MX2018001296A publication Critical patent/MX2018001296A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un proceso para la síntesis de ravidasvir e intermediarios útiles en la preparación de los mismos.
MX2018001296A 2015-08-03 2016-07-28 Proceso para la sintesis de ravidasvir. MX2018001296A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2015A002784A ITUB20152784A1 (it) 2015-08-03 2015-08-03 Processo per la sintesi di ravidasvir
PCT/EP2016/068019 WO2017021270A1 (en) 2015-08-03 2016-07-28 Process for the synthesis of ravidasvir

Publications (1)

Publication Number Publication Date
MX2018001296A true MX2018001296A (es) 2018-05-22

Family

ID=54364584

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001296A MX2018001296A (es) 2015-08-03 2016-07-28 Proceso para la sintesis de ravidasvir.

Country Status (6)

Country Link
EP (1) EP3331874A1 (es)
CN (1) CN108349950A (es)
IT (1) ITUB20152784A1 (es)
MX (1) MX2018001296A (es)
RU (1) RU2018107689A (es)
WO (1) WO2017021270A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091446A1 (en) * 2010-01-22 2011-07-28 Glaxosmithkline Llc Chemical compounds
CA2800509A1 (en) * 2010-05-24 2011-12-01 Presidio Pharmaceuticals, Inc. Inhibitors of hcv ns5a
CA2864342A1 (en) * 2012-02-13 2013-08-22 Presidio Pharmaceuticals, Inc. Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith

Also Published As

Publication number Publication date
WO2017021270A1 (en) 2017-02-09
EP3331874A1 (en) 2018-06-13
CN108349950A (zh) 2018-07-31
ITUB20152784A1 (it) 2017-02-03
RU2018107689A3 (es) 2019-12-24
RU2018107689A (ru) 2019-09-05

Similar Documents

Publication Publication Date Title
PH12017501365B1 (en) Novel promoter and uses thereof
MX2022016566A (es) Composiciones que comprenden una caseina y metodos para producir las mismas.
PH12016501763A1 (en) Multispecific antibodies
EP3122753A4 (en) Ibrutinib solid forms and production process therefor
IN2014CH00247A (es)
EP3957629C0 (en) METHOD FOR PRODUCING DEUTERATED HYDROXY-BENZBROMARON AND THEREOF INTERMEDIATE PRODUCTS
TW201613893A (en) Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
ZA201604838B (en) Process for the production of synthesis gas
EP3158073B8 (en) Compositions and methods for making (s)-norcoclaurine and (s)-norlaudanosoline, and synthesis intermediates thereof
IN2013MU00848A (es)
IN2013MU00646A (es)
GB201701396D0 (en) Novel alternating-phase synthesis method
MX2017003301A (es) Producto refractario, relleno para fabricar el producto, procedimiento para fabricar el producto y uso del producto refractario.
MX2020007742A (es) Procesos para preparar fluorocetolidos.
PH12020550871A1 (en) Process for the preparation of opicapone and intermediates thereof
HUE056799T2 (hu) Módszer specifikus természetes kapszaicinoidok mikrobiális elõállítására
EP3368537A4 (en) METHOD FOR THE PRODUCTION OF IBRUTINIB AND ITS INTERMEDIATE PRODUCTS
PH12017500499A1 (en) Synthesis of ent-progesterone and intermediates thereof
EP3141543B8 (en) Vortioxetine intermediate and synthesis process thereof
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
GB201721925D0 (en) a-cyanoacrylate production plant
MX2018001296A (es) Proceso para la sintesis de ravidasvir.
IS2977B (is) Aðferð til framleiðslu á milliefnum sem eru nytsamleg við nýsmíði á elúxadólíni
EP3285875A4 (en) PROCESS FOR SYNTHESIS OF CERAGENES